Efficacy of switching from originator etanercept to biosimilar YLB113 in real-world patients with rheumatoid arthritis: A retrospective 12 months follow-up study
Purpose: To investigate the disease activity in real-world patients with rheumatoid arthritis (RA) who switched from originator etanercept (ETN) to biosimilar YLB113. Methods: Forty one RA patients who switched from ETN to YLB113 were divided into 2 groups based on the Disease Activity Score based o...
Zapisane w:
| Główni autorzy: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publishing
2024-06-01
|
| Seria: | Journal of Orthopaedic Surgery |
| Dostęp online: | https://doi.org/10.1177/10225536241265818 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|